Lookup NU author(s): Dr Lisa Shaw,
Professor Helen Rodgers
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Spasticity is involuntary overactivity of muscles that occurs following upper motor neuron damage to the brain or spinal cord. Upper limb spasticity is common after stroke and can cause deformity, pain and reduced function. Botulinum toxin type A is a neurotoxin produced by the bacterium Clostridium botulinum that blocks the release of acetylcholine from cholinergic neurons. When given by intramuscular injection it causes temporary local paresis and has become an important component of focal spasticity treatment. Randomized controlled trials have shown that botulinum toxin type A can decrease upper limb spasticity and improve the ease of performing basic upper limb functional activities, such as cleaning the hand or dressing a sleeve. This article will review the pharmacology of botulinum toxin type A and its clinical efficacy when used to treat upper limb spasticity after stroke.
Author(s): Shaw L, Rodgers H
Publication type: Review
Publication status: Published
Journal: Expert Review of Neurotherapeutics
ISSN (print): 1473-7175
ISSN (electronic): 1744-8360